Sema4 Overview
- Founded
- 2017
- Status
- Public
- Stock Symbol
- SMFR
- Investments
- 2
- Share Price
- $3.05
- (As of Monday Closing)
Sema4 General Information
Description
Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
Contact Information
- 333 Ludlow Street
- North Tower, 8th floor
- Stamford, CT 06902
- United States
Sema4 Timeline
Sema4 Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.05 | $2.95 | $2.80 - $12.65 | $716M | 243M | 1.75M |
Sema4 Financials Summary
In Thousands, USD |
TTM 31-Dec-2019 | FY 2019 31-Dec-2019 |
---|---|---|
Revenue | 200,000 |
Sema4 Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Sema4‘s full profile, request access.
Request a free trialSema4 Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Sema4‘s full profile, request access.
Request a free trialSema4 Comparisons
Industry
000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSema4 Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
GeneDx | Corporate Backed or Acquired | Gaithersburg, MD | 000 | 000000&0 | ||
0000000 | Formerly VC-backed | San Francisco, CA | 0000 | 00000 | 000000000 | 00000 |
Sema4 Patents
Sema4 Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210110888-A1 | Method and system for assigning risk factors to individuals | Pending | 11-Oct-2019 | 000000000 | |
US-20200388353-A1 | Automatic annotation of significant intervals of genome | Pending | 06-Jun-2019 | 000000000 |
Sema4 Executive Team (28)
Sema4 Board Members (16)
Name | Representing | Role | Since |
---|---|---|---|
Andrew ElBardissi MD | Deerfield Management | Board Member | 000 0000 |
David Windreich | Sema4 | Board Member | 000 0000 |
Dennis Charney MD | Self | Board Member | 000 0000 |
Eli Casdin | CM Life Sciences | Board Member | 000 0000 |
Emily Leproust Ph.D | CM Life Sciences | Board Member | 000 0000 |
Sema4 Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Sema4‘s full profile, request access.
Request a free trialSema4 Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 | 18-Jan-2022 | 0000000000 | 00000 | Laboratory Services (Healthcare) | 0000 0000 |
CM Life Sciences | 22-Jul-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | 0000 0000 |